Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Belgium's drug regulator is warning patients about unauthorized stem cell clinics abroad — especially in Turkey — that promise cures for conditions like autism, MS, and Parkinson's. These treatments haven't passed EU safety standards and carry serious risks, from severe immune reactions to tumor complications. Doctors are being urged to proactively counsel vulnerable patients before they seek treatment abroad.
Belgium's Federal Agency for Medicines and Health Products (AFMPS) has issued a formal warning about "stem cell tourism" — the growing trend of patients traveling abroad, particularly to Turkey, to receive unauthorized stem cell therapies. Two Turkish facilities, Liv Hospital and You StemCell, are specifically named. These clinics aggressively market unproven treatments via social media and websites, targeting patients with conditions like autism, cerebral palsy, multiple sclerosis, Alzheimer's, and ALS — diseases where conventional medicine offers limited options.
The AFMPS is clear: these treatments have not undergone the rigorous quality, safety, and efficacy evaluations required under EU law. Legitimate stem cell therapies — like hematopoietic stem cell transplants for blood cancers — are tightly regulated through the European Medicines Agency (EMA). The unauthorized versions are a different story entirely, with documented risks including severe immune reactions, infections, tumor complications, and neurological damage.
Key Takeaways:
Why it matters: Desperate patients and families are prime targets for predatory marketing. Physicians are on the front lines — an informed, non-judgmental conversation in the clinic may be the most effective tool to prevent serious harm.
